NOR 3

• プロトコル NO を系の中に加えたい
  

1) Y. Kita, R. Ozaki, S. Sakai, T. Sugimoto, Y. Hirasawa, M. Ohtsuka, H. Senoh, K. Yoshida and K. Maeda, "Antianginal Effects of FK409, a New Spontaneous NO Releaser", Br. J. Pharmacol., 1994, 113, 1137.
2) Y. Kita, Y. Hirasawa, K. Yoshida and K. Maeda, "Antiplatelet Activities of FK409, a New Spontaneous NO Releaser", Br. J. Pharmacol., 1994, 113, 385.
3) M. Hino, M. Iwami, M. Okamoto, K. Yoshida, H. Haruta, M. Okuhara, J. Hosoda, M. Kohsaka, H. Aoki and H. Imanaka, "FK409, a Novel Vasodilator Isolated from the Acid-treated Fermentation Broth of Streptomyces Griseosporeus I. Taxonomy, Fermentation, Isolation, and Physico-chemical and Biological Characteristics", J. Antibiot., 1989 XLII(11), 1578.
4) S. Shibata, N. Satake, N. Sato, M. Matsuo, Y. Koibuchi and R. K. Hester, "Characteristics of the Vasorelaxing Action of (3E)-4-Ethyl-2-hydroxyimino-5-nitro-3-hexamide FK409, a New Vasodilator Isolated from Microbial Sources, in Isolated Rabbit Arteries", J. Cardiovasc. Pharmacol., 1991, 17(3), 508.
5) Y. Kita, Y. Hirasawa, K. Maeda, M. Nishio and K. Yoshida, "Spontaneous Nitric Oxide Release Accounts for the Potent Pharmacological Actions of FK409", Eur. J. Pharmacol., 1994, 257, 123.
6) J.-L. Decout, B. Roy, M. Fontecave, J.-C. Muller, P. H. Williams and D. Loyaux, "Decomposition of FK409, a New Vasodilator: Identification of Nitric Oxide as Metaborite", Bioorg. Med. Chem. Lett., 1995, 5(9), 973.
7) S. Fukuyama, Y. Kita, Y. Hirasawa, T. Azuma, A. Sato, N. Morokoshi, S. Koda, T. Yasuda, S. Oka and H. Sakurai, "A New Nitric Oxide (NO) Releaser: Spontaneous NO Release from FK409", Free Rad. Res., 1995, 23(5), 443.
8) Y. Kita, K. Ohkubo, Y. Hirasawa, Y. Katayama, M. Ohno, S. Nishino, M. Kato and K. Yoshida, "FR144420, a Novel, Slow, Nitric Oxide-releasing Agent", Eur. J. Pharmacol., 1995, 275, 125.
9) M. Kato, S. Nishino, M. Ohno, S. Fukuyama, Y. Kita, Y. Hirasawa, I. Nakanishi, H. Takasugi and K. Sakane, "New Reagents for Controlled Release of Nitric Oxide. Structure-stability Relationships", Bioorg. Med. Chem. Lett., 1996, 6(1), 33.
10) Y. Kita, Y. Hirasawa, S. Fukuyama and K. Yoshida, "FK409, a Novel Spontaneous NO Releaser: Comparative Pharmacological Studies with ISDN", Cardiovasc. Rrug. Revi., 1996, 14(2), 148.
11) Y. Hirasawa, T. Sugimoto, S. Fukuyama, Y. Kato, H. Takamatu, M. Ohno, S. Nishino, M. Kato, K. Maeda, J. Seki and Y. Kita, "Antianginal Effects of FR144420, a Novel Nitric Oxide-releasing Agent", Eur. J. Pharmacol., 1996, 303, 55.
12) M. Sato and M. Kawatani, "Nitric Oxide Raises Cytosolic Concentrations of Ca²⁺ in Cultured Nodose Ganglion Neurons from Rabbits", Neurosci. Lett., 1996, 206, 69.
13) Y. Kita, Y. Hirasawa, S. Fukuyama, K. Ohkubo, Y. Kato, H. Takamatsu, M. Ohno, S. Nishino, M. Kato and J. Seki, "Oral Biological Activities of Spontaneous Nitric Oxide Releaser are Accounted for by their Nitric Oxide-releaseing Rates and Oral Absorption Manners", J. Pharmacol. Exp. Ther., 1996, 276(2), 421.
14) S. Fukuyama, Y. Hirasawa, Y. Kato, M. Nishino, M. Ohno, S. Nishino, K. Maeda, M. Kato and Y. Kita, "Structure-activity Relationships of Spontaneous Nitric Oxide Releasers, FK409 and its Derivatives", J. Pharmacol. Exp. Ther., 1997, 282(1), 236.
15) Y. Kita, Y. Hirasawa, Y. Kato, K. Ohkubo, M. Ohno, S. Nishino, M. Kato and S. Fukuyama, "Comparison of Hemodynamic Effects of Nitric Oxide (NO) Donors with Different NO-releasing Properties in Rats", J. Cardiovasc. Pharmacol., 1997, 30(2), 223.
16) Y. Hirasawa, Y. Kato, S. Fukuyama, M. Ohno, S. Nishino, M. Kato and Y. Kita, "Comparison of Antiplatelet Effect of two Nitric Oxide-donating Agents, FR146801 and FK409", Thrombosis Haemost., 1998, 79, 620.